CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for InVitro International is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

InVitro International
330 E Orangethorpe Ave Ste D
Phone: (949) 851-8356p:949 851-8356 PLACENTIA, CA  92870  United States Ticker: IVROIVRO
This company ceased filing statements with the SEC on 10/10/1997.
Business Summary
InVitro International, Inc. is a customer and technology-driven provider of non-animal testing methods. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. The Company produces and sells in vitro assay kits to detect, rank and predict the potential level of irritancy, toxicity or corrosivity of substances on human eye (ocular) and/or skin tissue (dermal). It sells its products direct to customers, independent partner laboratories, and agents in the United States, Europe, Latin America and Asia. It also sells vitro products, which include Ocular Irritection, which is used to evaluate the potential for ocular irritation; Irritection Dermal, which is used to evaluate the potential for dermal irritation and Corrositex, which is used to determine corrosivity level classifications. It also conducts laboratory testing for those customers who prefer not to conduct their own tests.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20109/30/1996YesYes---

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
2834 Pharmaceutical preparations
8734 Testing laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Irwin J.Gruverman 78 4/23/1993 3/11/1993
President, Chief Executive Officer, Director W. RichardUlmer 59 11/15/1994 11/15/1994
Senior Vice President, Director Dennis E.Chenoweth 57 8/24/1995 2/21/1995
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 16 (As of 9/30/1999)
Outstanding Shares: 22,759,809 (As of 2/13/2020)
Shareholders: 419
Stock Exchange: OTC
Federal Tax Id: 330149560
Fax Number: (949) 851-4985


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023